We are live on
!
Find out more
Royalty Pharma
RPRX
RPRX
283 hedge funds and large institutions have $12.2B invested in Royalty Pharma in 2022 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 108 increasing their positions, 81 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,273% more call options, than puts
Call options by funds: $75.8M | Put options by funds: $5.52M
33% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 81
18% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 44
16% more capital invested
Capital invested by funds: $10.5B → $12.2B (+$1.71B)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
4.4% more ownership
Funds ownership: 62.46% → 66.86% (+4.4%)
1% more funds holding
Funds holding: 279 → 283 (+4)
Holders
283
Holders Change
+4
Holders Change %
+1.43%
% of All Funds
4.77%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.17%
New
52
Increased
108
Reduced
81
Closed
44
Calls
$75.8M
Puts
$5.52M
Net Calls
+$70.3M
Net Calls Change
+$35M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$691M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$318M |
| 3 |
JP Morgan Chase
New York
|
+$85.6M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$80.7M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$65.8M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$333M |
| 2 |
Morgan Stanley
New York
|
-$81.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$73.7M |
| 4 |
VCG
Vantage Consulting Group
Virginia Beach,
Virginia
|
-$68.7M |
| 5 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$58.3M |
